# reload+after+2024-01-19 22:47:40.319404
address1§400 Oyster Point Boulevard
address2§Suite 505
city§South San Francisco
state§CA
zip§94080
country§United States
phone§650 244 4990
fax§650 244 4956
website§https://www.titanpharm.com
industry§Biotechnology
sector§Healthcare
longBusinessSummary§Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. It develops products based on ProNeura, a proprietary long-term drug delivery platform. The company offers Probuphine implant for the maintenance treatment of opioid use disorder in clinically stable patients in the United States, Canada, and the European Union. It also develops TP-2021 in combination with ProNeura technology for the treatment of chronic pruritus, a severe and debilitating condition defined as itching of the skin lasting longer than six weeks; Nalmefene implant program for the prevention of opioid relapse following detoxification of patients suffering opioid use disorder; and other programs, including HIV preventative therapeutic and a contraceptive from a single ProNeura implant for women and adolescent girls. The company was incorporated in 1992 and is based in South San Francisco, California.
fullTimeEmployees§4
companyOfficers§[{'maxAge': 1, 'name': 'Mr. David Elliot Lazar', 'age': 32, 'title': 'CEO & Principal Financial Officer', 'yearBorn': 1991, 'fiscalYear': 2022, 'totalPay': 726080, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Katherine L. Beebe-DeVarney Ph.D.', 'age': 62, 'title': 'President, COO & Director', 'yearBorn': 1961, 'fiscalYear': 2022, 'totalPay': 308000, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Mike  Fritz', 'title': 'National Sales Director', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Jennifer  Kiernan', 'title': 'Executive Assistant to CEO & Investor Communications Coordinator', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Joe  Schrei', 'title': 'Executive Director of Commercial Operations', 'fiscalYear': 2022, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1672444800
maxAge§86400
priceHint§4
payoutRatio§0.0
beta§1.274
priceToSalesTrailing12Months§20.979204
currency§USD
dateShortInterest§1702598400
forwardEps§-0.91
exchange§NCM
quoteType§EQUITY
shortName§Titan Pharmaceuticals, Inc.
longName§Titan Pharmaceuticals, Inc.
firstTradeDateEpochUtc§821975400
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§64c32c20-53ef-3d4e-b193-5cffb753cb0b
gmtOffSetMilliseconds§-18000000
recommendationMean§3.0
recommendationKey§hold
quickRatio§5.156
grossMargins§0.0
ebitdaMargins§0.0
trailingPegRatio§None
